Elham Ramezanzade, S. Nikfarjam, Masoomeh Namdar, Fatemeh nejatifar
{"title":"Correlation between Fibroblast Growth Factor 23 and C-reactive Protein in Hemodialysis Patients","authors":"Elham Ramezanzade, S. Nikfarjam, Masoomeh Namdar, Fatemeh nejatifar","doi":"10.52547/sjimu.30.1.65","DOIUrl":null,"url":null,"abstract":"12.94±8.82. In multiple linear regression analysis, after controlling the effect of confounding variables (individual variables, blood parameters, and underlying diseases), there was a direct and significant relationship between iFGF23 and CRP (P=0.010, 𝜷 =0.129, CI=0.032-0.226). Discussion & Conclusion: The present study showed that increased FGF23 levels are independently associated with increased CRP levels in patients with ESRD. Future studies should evaluate whether inflammation alters the association between elevated FGF23 levels and adverse clinical outcomes in ESRD.","PeriodicalId":16041,"journal":{"name":"journal of ilam university of medical sciences","volume":"63 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"journal of ilam university of medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52547/sjimu.30.1.65","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
12.94±8.82. In multiple linear regression analysis, after controlling the effect of confounding variables (individual variables, blood parameters, and underlying diseases), there was a direct and significant relationship between iFGF23 and CRP (P=0.010, 𝜷 =0.129, CI=0.032-0.226). Discussion & Conclusion: The present study showed that increased FGF23 levels are independently associated with increased CRP levels in patients with ESRD. Future studies should evaluate whether inflammation alters the association between elevated FGF23 levels and adverse clinical outcomes in ESRD.